TheStreet25d agobullish
Schwab SCHD draws $679M as dividend ETF climbs 2.39%Three catalysts, one reshuffling, and a Fed that refuses to move
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
68last 24h
974last 7d
109● bullish (7d)
123● bearish (7d)
212publishers
Reuters52d agobullish
GE HealthCare beats quarterly profit estimates on strong imaging demand, tariff refundsJuly 29 () - GE HealthCare on Wednesday beat Wall Street estimates for second-quarter profit, helped by strong demand for its diagnostic and imaging devices and refunds of tariffs imposed under U. Shares of the medical device maker rose 12% in premarket trading.
Reuters52d agobullish
GE HealthCare beats quarterly profit estimates on strong imaging demand, tariff refundsJuly 29 (Reuters) - GE HealthCare on Wednesday beat Wall Street estimates for second-quarter profit, helped by strong demand for its diagnostic and imaging devices and refunds of tariffs imposed
Proactive65d agobullish
Abbott Laboratories shares jump as earnings beat estimates and company raises 2026 outlookAbbott Laboratories (NYSE:ABT) shares rose nearly 11% on Thursday after the healthcare company reported second quarter 2026 results that topped Wall Street expectations and raised its full-year adjusted earnings guidance. The company posted adjusted diluted earnings per share of $1.31 for the...
Quartz65d agobullish
Abbott Q2 2026 earnings beat, raises full-year profit guidanceThe healthcare company posted adjusted earnings of $1.31 a share in the second quarter, topping Wall Street's estimate of $1.28
InvestorsHub65d agobullish
Abbott raises 2026 earnings outlook after second-quarter results beat expectations (ABT)Abbott Laboratories (NYSE:ABT) delivered stronger-than-expected second-quarter results and increased its full-year earnings guidance, sending its shares about 2. 5% higher in premarket trading.
Investing.com65d agobullish
Abbott beats second-quarter estimates, raises 2026 guidanceInvesting.com -- Abbott (NYSE:ABT) shares are trading higher premarket on Thursday after the company reported second-quarter earnings, topping consensus expectations and raising its full-year earnings guidance.
Zacks101d agobullish
Is Medtronic Stock a Buy at 14x Forward Earnings?MDT trades at about 14x forward earnings with a 3.5% yield as fiscal 2027 guidance points to steady growth, but margins face tariffs and mix pressure.